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femoral aortogram. Although the cardiac failure was not a con-
traindication to open surgery, in view of the risk of significant blood
loss associated with conventional repair, endovascular stent-graft
repair was considered to be a more suitable therapeutic option.
The anatomy of the aortoiliac segment was assessed. The
infrarenal aorta had a proximal neck of a 29-mm diameter and was
more than 20 mm long. The fistula was at the junction of the aorta
and right common iliac artery, which was also aneurysmal. An
endovascular graft would have to extend to the right external iliac
artery, which was 8.5 mm in diameter. On the left side, the common
iliac artery was again aneurysmal and unsuitable for an endovascular
graft. In consultation with a number of endovascular colleagues and
commercial companies, we chose to use an aortouni-iliac device with
a femorofemoral crossover graft from the right to left side. This was
dictated by the size of the aortic graft required and by a desire to
maintain patency of at least one internal iliac artery. The right inter-
nal iliac artery was embolized with metallic coils 2 days before the
endovascular repair to prevent back bleeding into the aneurysmal
right common iliac artery. A custom-made commercial aortouni-
iliac stent-graft with a 32-mm diameter aortic component, an 18-
mm diameter iliac limb, and a 105-mm length (Talent; World
Medical, Middlesex, England) and an extension stent-graft with a
20-mm proximal diameter, a 10-mm distal diameter, and a 110-mm
length (World Medical) were used via the right transfemoral route.
These were introduced using 24F and 22F delivery systems, respec-
tively, with the distal attachment placed at the right external iliac
artery. The left common iliac artery was also embolized with metal-
lic coils after successful deployment of the stent-grafts to exclude
inflow into the aneurysm sac. The arterial inflow to the left leg was
achieved with a right-to-left femorofemoral crossover graft with an
8-mm knitted Dacron tube graft (Vascutek, Renfrewshire,
Scotland). An intraoperative completion arteriogram with delayed
views showed complete exclusion of the aneurysm with no evidence
of endoleak and closure of the ACF (Fig 3). The perioperative blood
loss was 370 mL.
A Swan-Ganz catheter and central venous catheter were used
perioperatively to monitor the cardiac output and the central
venous pressure. After successful exclusion of the ACF, the cardiac
output dropped from 14 L/min (preoperative) to 4 L/min, and
the central venous pressure dropped from 35 mm Hg (preopera-
tive) to 15 mm Hg. The mixed venous oxygen saturation reduced
from 90% (preoperative) to 70%. Immediately after exclusion of
the ACF, the patient developed severe systemic hypertension (sys-
tolic blood pressure > 200 mm Hg), which required glyceryl trini-
Endovascular stent-grafts have been successfully used
in the management of arteriovenous fistulas since the early
1990s.1,2 However, their use in the management of pri-
mary aortocaval fistula (ACF) has only been reported on
two occasions.3,4 We describe a case of an ACF in associa-
tion with an abdominal aortoiliac aneurysm that was man-
aged with an endovascularly placed aortouni-iliac
stent-graft and a femorofemoral crossover bypass graft.
CASE REPORT
A 61-year-old man presented to a District General Hospital
with a 3-month history of increasing shortness of breath, orthopnea,
bilateral ankle swelling, and abdominal distension. He had no past
history of cardiac or respiratory problems. Clinically, he had signs
suggestive of congestive cardiac failure with ascites, gross facial,
truncal, and lower limb edema, orthopnea and shortness of breath
on minimal exertion. Chest examination revealed bilateral pleural
effusions with no significant crepitations. A coincidental finding was
an abdominal aortic aneurysm (AAA) associated with a continuous
abdominal bruit. Initially, computed tomography (CT) confirmed a
5.5-cm infrarenal aortoiliac aneurysm with no evidence of extravas-
cular leakage. Blood biochemistry revealed normal cardiac enzymes,
but there was a moderate degree of renal and hepatic impairment
with the following abnormal levels: urea 19.3 mmol/L, creatinine
221 µmol/L, aspartate transaminase 70 U/L, alanine transaminase
80 U/L, bilirubin 30 µmol/L. Intensive diuretic and inotropic
therapy was ineffective, and the patient’s condition deteriorated.
Subsequently, he was transferred to a tertiary cardiology unit for fur-
ther management. An echocardiogram showed apical hypokinesia of
the left ventricle with ejection fraction of 60%. The inferior vena cava
(IVC) and hepatic vein were of normal size. A spiral CT showed the
presence of a fistula between the IVC and the AAA just at the aor-
tic bifurcation (Figs 1 and 2). This was further confirmed by a trans-
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A primary aortocaval fistula is present in less than 1% of all abdominal aortic aneurysms. Until recently, surgical repair
was the only method of treatment and was associated with a high incidence of morbidity and mortality. With the rapid
development of aortic stent-graft technique, endovascular stent-graft repair may offer an alternative to the management
of this often fatal condition. We report a case of an aortoiliac aneurysm with an aortocaval fistula successfully treated
with endovascular stent-grafting. The unique hemodynamic changes, technical problems, and complications associated
with this case are discussed, and the literature is reviewed. (J Vasc Surg 2001;33:425-8.)
trate infusion and sublingual nifedipine perioperatively and for 6
hours after surgery. The patient was initially managed in the inten-
sive care unit for 20 hours and later transferred to the vascular unit.
Postoperatively, his cardiac indices normalized, and he had spon-
taneous diuresis (8000 mL in the first 24 hours, up to 6000 mL
on subsequent days). His renal and hepatic functions also returned
to normal levels at day 2 postoperatively (urea 8 mmol/L, creati-
nine 137 µmol/L, aspartate transaminase 40 U/L, alanine
transaminase 45 U/L, and bilirubin 15 µmol/L). However, a
repeat spiral CT and arteriography at day 7 showed a persistent fis-
tula with a small inflow from the left common iliac system that was
not present on the intraoperative completion arteriogram. The
coils had clearly not occluded the left common iliac artery. Insofar
as the patient’s cardiac status had now significantly improved, it
was felt reasonable to ligate the left common iliac artery via an
extraperitoneal approach on day 8. This was achieved without sur-
gical difficulty. The patient was discharged on day 18. Two weeks
later, he was readmitted with acute ischemia of both legs.
Arteriography confirmed occlusion of the aortic stent-graft. An
intra-aortic catheter was inserted through the brachial artery, and
low-dose infusion of tissue plasminogen activator was given over
the following 19 hours to a total of 20 mg. Postthrombolysis arte-
riography showed a patent graft with good runoff and no evidence
of any endoleaks or persistence of ACF. However, there was a per-
sistent stenosis at the junction between the aortouni-iliac graft and
the iliac extension graft with no evidence of graft angulation. This
had not been present on the intraoperative completion arteri-
ogram. The stenosis was balloon angioplastied with good results.
The patient was well at a 12-month review. A repeat CT showed a
patent graft, and the aneurysm remained excluded with no evi-
dence of fistula.
DISCUSSION
Primary ACF due to spontaneous erosion of the
aneurysm into the vena cava accounts for 80% of all
reported cases of ACF. Most of these aneurysms are ath-
erosclerotic in nature. Traumatic or iatrogenic causes are
responsible for the remaining 20% of ACFs.
ACF was first described by Syme in 1831.5 In 1938,
Lehman6 attempted the first repair of an ACF in a patient
with syphilitic aneurysm, but the patient died within 15
hours. It was not until 1954 that Cooley7 carried out the
first successful repair of a spontaneous ACF. Primary ACF
is a rare complication of AAA and involves less than 1% of
all AAAs.8 The symptoms and signs of ACF are well
described in the literature.9 However, the diagnosis may
not be apparent at clinical examination, especially if the
ACF is associated with an extravascular leakage when
hypovolemia may mask the clinical signs. The classically
described triad of severe abdominal pain or back pain,
machinery-like abdominal bruit, and a pulsatile abdominal
mass may be seen in only 50% to 80% of cases. More
important, the symptoms of ACF mimic other more com-
mon cardiac and noncardiac conditions, making preoper-
ative diagnosis difficult. Some authors report a high
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Fig 1. Contrast-enhanced spiral CT angiogram showing
infrarenal AAA and ACF just above aortic bifurcation.
Fig 2. Contrast-enhanced spiral CT with three-dimensional
reconstruction showing aortic aneurysm and its communication
with IVC at above aortic bifurcation.
The intraoperative completion arteriogram did not
show any persistent leak, even on delayed views. Follow-
up CT showed the presence of an endoleak on day 7. It
may be that in such cases where the potential for endoleak
is high, that completion angiogram should not be taken as
a reliable guide and adjunctive techniques such as early CT
or duplex ultrasound scan should be routine.23,24 The
graft thrombosis we encountered was a major concern,
but it responded well to thrombolysis. Recombinant tissue
plasminogen activator was administered in a low-dose
infusion via a thrombolysis catheter inserted into the
thrombosed segment. The stenosis found after thrombol-
ysis was in the region of the right common iliac bifurca-
tion and was treated with balloon angioplasty. Although
repeat CT did not show any anatomic abnormality in this
region in our patient, most reported graft thromboses
after endovascular repair have been due to graft deforma-
tion and angulation. These would seem to be best treated
with the insertion of a Wallstent.25 This may have also
been prudent in our case.
One of the interesting aspects of our case was the
hemodynamic changes that occurred after the insertion
and deployment of the aortic stent-graft. As the fistula was
being occluded, there was a sudden rise of the systemic vas-
cular resistance as the left-to-right shunting phenomenon
of the ACF was abolished. The reduced preload to the ven-
tricle also led to improved cardiac performance. Although
the cardiac output dropped significantly from 14 L/min to
4 L/min, there was a relatively larger increase in systemic
vascular resistance, from 437 dyne/s/cm-5 to 1889
dyne/s/cm-5 (normal range, 770-1500), which led to the
severe systemic hypertension and the requirement for
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percentage of symptom-free ACF; many cases are recog-
nized only during surgery.10
Aortography is the most accurate study for establish-
ing a diagnosis of ACF.9,11 However, the role of aortog-
raphy in the preoperative evaluation of patients with AAA
remains controversial because a minimal but definite mor-
bidity and time wastage are associated with the procedure.
Contrast-enhanced spiral computed tomography has been
demonstrated to be as useful in establishing the diagnosis
of ACF with its characteristic findings of caval effacement,
loss of fat plain between the aorta and vena cava, and rapid
flow of contrast from the aorta into a dilated IVC.11
Until recently, surgical repair was the only treatment
for patients with ACF. Open repair is associated with a
mortality rate of 30%, especially in patients with cardiovas-
cular decompensation.3,4,8 Endovascular stent-grafting
offers an attractive therapeutic alternative to the open
repair of ACF. Boudghene et al12 reported successful treat-
ment of ACF with percutaneous stent-grafts in an experi-
mental study in which the ACF was created percutaneously
in eight sheep. There have been a number of reported cases
of endovascular stent-grafts in the management of trau-
matic or iatrogenic arteriovenous fistulas.1,2 However, the
use of an endovascular stent-graft in the repair of a sponta-
neous ACF complicating an AAA has only been reported
on two occasions.3,4 Such application was not without
technical problems. In their case, Beveridge et al3 described
difficulty in the introduction and deployment of the con-
tralateral limb of the bifurcated stent-graft due to the dis-
placement of the common iliac artery by the aneurysm.
Umscheid and Stelter4 used a bifurcated stent-graft in their
case because the distal aortic neck was very short and the
iliac vessels had a normal caliber. However, postoperative
CT showed that one of the iliac limbs of the bifurcated
graft was compressed by the narrow distal cuff of the
aneurysm, which they comment may become a source of
limb occlusion or claudication in the future.
In our case, the common iliac arteries were aneurysmal on
both sides; thus, we chose to use an aortouni-iliac stent-graft
with an extension and a femorofemoral crossover bypass graft
to preserve the left internal iliac artery. The use of this config-
uration in AAA repair was well described at that time.13-17 A
pitfall of this configuration is that occlusion of the contralateral
common iliac artery and an extra-anatomic bypass graft is
required. In the course of our procedure, we encountered a
number of complications that are worth discussing. We used
intraoperative coil embolization to occlude the common iliac
artery, and this later proved to be inadequate. Subsequent sur-
gical ligation was necessary. The failure of metallic coils to pro-
duce a permanent occlusion in large arteries is well
documented.13-15 Since this procedure was carried out,
endovascular occluder devices have become available and are
particularly effective for high-flow, large diameter vessels.17-22
An alternative was to use a bifurcated graft and sacrifice
both internal iliac vessels. Commercial bifurcated modular
grafts with an aortic size greater than 30 mm are now avail-
able, but at the time, our only option would be have a
homemade device with all its attendant risks.3,4
Fig 3. Intraoperative angiograms showing successful deployment
of stent-grafts and exclusion of ACF. Right internal iliac artery (A)
and left common iliac artery (B) were embolized with metallic
coils. Inflow to left leg was achieved with crossover graft (C).
aggressive perioperative treatment. This hemodynamic
phenomenon has not been described before and may not
be encountered in open repair because of concurrent aor-
tic cross-clamping and hemorrhage. A short duration of
glyceryl trinitrate infusion was effective, and after a few
days of marked diuresis, the patient’s blood pressure stabi-
lized and required no further antihypertensive treatment.
In all, his weight decreased from 110 to 79 kg.
Endovascular stent-grafting may provide an attractive
and minimally invasive treatment alternative to open repair
of ACF, especially in cases when a preoperative diagnosis
can be made. This averts the significant blood loss com-
monly encountered in conventional repair and may reduce
the significant morbidity and mortality rates often associ-
ated with open surgery. Unlike a rupture or contained rup-
ture of an AAA, spontaneous ACF may not always require
emergency treatment, and time may be available for
obtaining the suitable endovascular stent-graft. However,
in cases of ruptured AAA with associated ACF, the tech-
nique may offer its greatest benefits. With the availability of
an off-the-shelf endovascular stent-graft, the use of
endovascular technique in emergency cases can be evalu-
ated.26 Clearly, its application is not without hazard or
complications, and careful planning is mandatory at all
steps, from patient selection, accurate preoperative assess-
ment, and angiographic measurement for stent-graft man-
ufacturing to actual placement of the stent-graft and
perioperative care of patients. A multidisciplinary approach
is often desirable with good cooperation among the vascu-
lar surgeon, cardiologist, anesthetist, and the interventional
radiologist. With further improvement in preoperative
diagnostic technique and stent-graft design, the long-term
result of endovascular stent-grafting is awaited.
REFERENCES
1. Parodi JC. Endovascular repair of aortic aneurysms, arteriovenous fis-
tulas, and false aneurysms. World J Surg 1996;20:655-63.
2. Marin ML, Veith FJ, Panetts TF, Cynamon J, Sanchez LA, Schwartz
ML, et al. Transluminally placed endovascular stented graft repair for
arterial trauma. J Vasc Surg 1994;20:466-72.
3. Beveridge CJ, Pleass HC, Chamberlain J, Wyatt MG, Rose JD.
Aortoiliac aneurysm with arteriocaval fistula treated by a bifurcated
endovascular stent-graft. Cardiovasc Intervent Radiol 1998;21:244-6.
4. Umscheid T, Stelter W-J. Endovascular treatment of an aortic aneurysm
ruptured into the inferior vena cava. J Endovasc Ther 2000;7:31-5.
5. Syme J. Case of spontaneous varicose aneurysm. Edinb Med Surg J
1831;36:104-5.
6. Lehman EP. Spontaneous arteriovenous fistula between the abdomi-
nal aorta and the inferior vena cava: case report. Ann Surg 1938;108:
694-700.
7. Cooley DA. Discussion of paper by Javid and Coll: resection of rup-
tured aneurysms of abdominal aorta. Ann Surg 1955;142:623.
8. Fenster MS, Dent JM, Tribble C, Angle JF, Sarembock IJ, Komada M,
et al. Aortocaval fistula complicating abdominal aortic aneurysm: case
report and literature review. Cathet Cardiovasc Diagn 1996;38:75-9.
9. Bednarkiewicz M, Pretre R, Kalangos A, Khatchatourian G,
Bruschweiler I, Faidutti B. Aortocaval fistula associated with abdominal
aortic aneurysm: a diagnostic challenge. Ann Vasc Surg 1997;11:464-6.
10. Ghilardi G, Scorza R, Bortolani E, de Monti M, Longhi F, Ruberti U.
Primary aortocaval fistula. Cardiovasc Surg 1994;2:495-7.
11. Rosenthal D, Atkins CP, Jerrius HS, Clark MD, Matsuura JH.
Diagnosis of aortocaval fistula by computed tomography. Ann Vasc
Surg 1998;12:86-7.
12. Boudghene F, Sapoval M, Bonneau M, Bigot JM. Aortocaval fistulae:
a percutaneous model and treatment with stent grafts in sheep.
Circulation 1996;94:108-12.
13. Chuter TA, Faruqi RM, Reilly LM, Kerlan RK, Sawhney R, Wall SD,
et al. Aortomonoiliac endovascular grafting combined with femoro-
femoral bypass: an acceptable or a preferred solution? Semin Vasc Surg
1999;12:176-81.
14. Walker SR, Braithwaite B, Tennant WG, MacSweeney ST, Wenham
PW, Hopkinson BR. Early complications of femorofemoral crossover
bypass grafts after aorta uni-iliac endovascular repair of abdominal aor-
tic aneurysms. J Vasc Surg 1998;28:647-50.
15. Thompson MM, Sayers RD, Nasim A, Boyle JR, Fishwick G, Bell PR.
Aortomonoiliac endovascular grafting: difficult solutions to difficult
aneurysms. J Endovasc Surg 1997;4:174-81.
16. Ivancev K, Malina M, Lindblad B, Chuter TA, Brunkwall J, Lindh M, et
al. Abdominal aortic aneurysms: experience with the Ivancev-Malmo
endovascular systemic for aortomonoiliac stent-grafts. J Endovasc Surg
1997;4:242-51.
17. Marin ML, Veith FJ, Cynamon J, Sanchez LA, Lyon RT, Levine BA, et
al. Initial experience with transluminally placed endovascular grafts for
the treatment of complex vascular lesions. Ann Surg 1995;222:449-65.
18. Kato N, Semba CP, Dake MD. Use of a self-expanding vascular
occluder for embolization during endovascular aortic aneurysm repair.
J Vasc Interv Radiol 1997;8:27-33.
19. Sharafuddin MJ, Gu X, Cervera-Ceballos JJ, Urness M, Amplatz K.
Repositionable vascular occluder: experimental comparison with stan-
dard Gianturco coils. J Vasc Interv Radiol 1996;7:695-703.
20. Moss JG, Laborde JC, Clem MC, Rivera FJ, Encarnacion CE, Meyer
KB, et al. Vascular occlusion with a balloon-expandable occluder.
Radiology 1994;191:483-6.
21. Ohki T, Veith FJ, Sanchez LA, Marin ML, Cynamon J, Parodi JC.
Varying strategies and devices for endovascular repair of abdominal
aortic aneurysms. Semin Vasc Surg 1997,10:242-56.
22. Ohki T, Veith FJ. Five-year experience with endovascular grafts for the
treatment of aneurysmal, occlusive and traumatic arterial lesions.
Cardiovasc Surg 1998;6:552-65.
23. Fillinger MF. Postoperative imaging after endovascular AAA repair.
Semin Vasc Surg 1999;12:327-38.
24. Gilling-Smith GL, Martin J, Sudhindran S, Gould DA, McWilliams RG,
et al. Freedom from endoleak after endovascular aneurysm repair does
not equal treatment success. Eur J Vasc Endovasc Surg 2000;19:421-5.
25. Silberzweig JE, Marin ML, Hollier LH, Mitty HA, Parsons RE,
Cooper JM. Aortoiliac aneurysms: endoluminal repair—clinical evi-
dence for a fully supported stent-graft. Radiology 1998;209:111-6.
26. Ohki T, Veith FJ, Sanchez LA, Cynamon J, Lipsitz EC, Wain RA, et
al. Endovascular graft repair of ruptured aortoiliac aneurysms. J Am
Coll Surg 1999;189:102-12.
Submitted Mar 10, 2000; accepted Jul 26, 2000.
JOURNAL OF VASCULAR SURGERY
428 Lau et al February 2001
